Received Jun 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB030A | — |
Expired dose administered.; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB030A, expiry date 30-APR-2025) for prophylaxis. On 03-JUN-2025, the patient received Menveo. On 03-JUN-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Expired dose administered.). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 03-JUN-2025 The reporter had a patient received Menveo at the time of reporting, but it was expired, which led to expired vaccine used. They were wondering when we should revaccinate. The reporter consented to follow up by email.